Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia

Authors
Publication date
19 May 2014
Publisher

Abstract

manuscriptSupporting information to Combined STAT3 and BCR-ABL1 Inhibition Induces Synthetic Lethality in Therapy-Resistant Chronic Myeloid Leukemi

    Similar works

    Full text

    thumbnail-image

    Available Versions

    The University of Utah: J. Willard Marriott Digital Library

    redirect
    oaioai:collections.lib.utah.edu:i...
    Last time updated on 01/01/2020